A company’s board has refused to accept a hostile takeover even after billionaire Larry Ellison offered a $40 billion guarantee to support the bid. The decision signals a hard line from the board and sets up a tense standoff with the would-be acquirer.
The board’s position emerged this week as advisers on both sides worked through financing details and strategic options. The target, which has not been named by the parties, is weighing legal, financial, and operational risks tied to the approach. The refusal suggests the board believes the offer undervalues the company or threatens its strategy and control.
“Board unwilling to accept hostile takeover despite $40bn guarantee from billionaire Larry Ellison.”
Hostile bids are uncommon but not rare, and they often test the limits of corporate defenses. A high-dollar financing pledge can sway shareholders, but it does not force a board to yield. Directors must still judge whether the deal is fair and in the best interests of investors.
The Offer and the Pushback
The guarantee from Ellison is striking in size. A $40 billion backstop suggests access to deep capital and confidence in the target’s potential under new control. It is designed to reassure lenders, shareholders, and ratings firms that the buyer can close.
Despite that, the board has pushed back. Directors often cite valuation gaps, cultural fit, antitrust exposure, and execution risks. They also consider whether synergies are realistic and whether debt loads would weaken the company after the takeover.
Without agreement, the bidder could take the proposal directly to shareholders. That route can trigger a proxy fight to replace directors with nominees who support the deal.
Why Boards Resist Hostile Deals
Directors have a duty to seek the best value for shareholders, but they can reject offers they view as inadequate. They can adopt a rights plan, often called a “poison pill,” to slow a bidder. They can run a formal sale process to test the market for higher bids.
Boards also consider long-term plans. If a company is mid-turnaround, directors may argue that a near-term premium shortchanges future gains. If the deal relies on heavy borrowing, they may worry about layoffs, asset sales, and lost investment in research and development.
Labor and customer concerns matter too. Key clients can balk at ownership changes. Employees may fear job cuts. These reactions can affect the company’s outlook and the success of any integration.
Ellison’s Role and Deal History
Ellison, the co-founder of Oracle, is known for bold moves in enterprise software. Oracle’s long battle to acquire PeopleSoft two decades ago reshaped that sector. He has backed big-ticket investments and has the means to support large transactions.
A personal guarantee of this size is unusual. It signals that the bidder can fund the offer even if markets turn choppy. It also raises the stakes. If the board remains opposed, the dispute could escalate into litigation or a proxy contest.
What It Means for Shareholders
Shareholders face a choice between a cash-out at a takeover price and a long-term bet on the current plan. The outcome often turns on who makes the stronger case on value and risk.
- If the bidder goes hostile, expect a proxy fight focused on board seats.
- If the board opens a sale process, other bidders could emerge.
- If talks continue, a higher price or deal protections may follow.
Debt markets will also watch the financing. A large guarantee can lower financing costs, but higher interest rates and leverage could still weigh on the combined company.
What Comes Next
Several paths are possible. The bidder may seek to rally shareholders and push for a vote. The board may adopt further defenses or invite competing bids to test the offer. Regulators could review any agreement for antitrust concerns, which can delay or derail a deal.
Both sides will work to win public opinion and investor support. Expect detailed presentations on strategy, synergy estimates, and stand-alone plans. Proxy advisers could influence the outcome if a vote on directors or the deal is scheduled.
The board’s refusal, even in the face of a $40 billion guarantee, sets a high bar for any acquirer. Investors should watch for a price bump, a shift to a proxy campaign, or a formal auction process. The next few weeks will show whether the bidder can convert financial muscle into shareholder votes, or whether the board’s stance holds.
